201 related articles for article (PubMed ID: 32853747)
21. New proposal for the serum ascites albumin gradient cut-off value in Chinese ascitic patients.
Jiang CF; Shi B; Shi J; Yuan ZL; Xie WF
Diagn Pathol; 2013 Aug; 8():143. PubMed ID: 23971938
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic paracentesis. A two-step approach.
Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
[TBL] [Abstract][Full Text] [Related]
23. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
Khandwalla HE; Fasakin Y; El-Serag HB
Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
[TBL] [Abstract][Full Text] [Related]
24. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis.
Telem DA; Schiano T; Goldstone R; Han DK; Buch KE; Chin EH; Nguyen SQ; Divino CM
Clin Gastroenterol Hepatol; 2010 May; 8(5):451-7, quiz e58. PubMed ID: 20036761
[TBL] [Abstract][Full Text] [Related]
25. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites.
Sinha R; Lockman KA; Mallawaarachchi N; Robertson M; Plevris JN; Hayes PC
J Hepatol; 2017 Jul; 67(1):40-46. PubMed ID: 28213164
[TBL] [Abstract][Full Text] [Related]
26. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
Dittrich S; Yordi LM; de Mattos AA
Hepatogastroenterology; 2001; 48(37):166-8. PubMed ID: 11268957
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.
Serra MA; Puchades MJ; Rodríguez F; Escudero A; del Olmo JA; Wassel AH; Rodrigo JM
Scand J Gastroenterol; 2004 Nov; 39(11):1149-53. PubMed ID: 15545175
[TBL] [Abstract][Full Text] [Related]
28. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Gentilini P; Casini-Raggi V; Di Fiore G; Romanelli RG; Buzzelli G; Pinzani M; La Villa G; Laffi G
J Hepatol; 1999 Apr; 30(4):639-45. PubMed ID: 10207805
[TBL] [Abstract][Full Text] [Related]
29. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
[TBL] [Abstract][Full Text] [Related]
30. Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.
Moreau R; Elkrief L; Bureau C; Perarnau JM; Thévenot T; Saliba F; Louvet A; Nahon P; Lannes A; Anty R; Hillaire S; Pasquet B; Ozenne V; Rudler M; Ollivier-Hourmand I; Robic MA; d'Alteroche L; Di Martino V; Ripault MP; Pauwels A; Grangé JD; Carbonell N; Bronowicki JP; Payancé A; Rautou PE; Valla D; Gault N; Lebrec D;
Gastroenterology; 2018 Dec; 155(6):1816-1827.e9. PubMed ID: 30144431
[TBL] [Abstract][Full Text] [Related]
31. Two findings of portal hypertension: evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis.
Demirel U; Karincaoğlu M; Harputluoğlu M; Ateş M; Seçkin Y; Yildirim B; Hilmioğlu F
Turk J Gastroenterol; 2003 Dec; 14(4):219-22. PubMed ID: 15048594
[TBL] [Abstract][Full Text] [Related]
32. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
[TBL] [Abstract][Full Text] [Related]
33. The association between the serum sodium level and the severity of complications in liver cirrhosis.
Kim JH; Lee JS; Lee SH; Bae WK; Kim NH; Kim KA; Moon YS
Korean J Intern Med; 2009 Jun; 24(2):106-12. PubMed ID: 19543488
[TBL] [Abstract][Full Text] [Related]
34. Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis.
Macken L; Bremner S; Gage H; Touray M; Williams P; Crook D; Mason L; Lambert D; Evans CJ; Cooper M; Timeyin J; Steer S; Austin M; Parnell N; Thomson SJ; Sheridan D; Wright M; Isaacs P; Hashim A; Verma S
Aliment Pharmacol Ther; 2020 Jul; 52(1):107-122. PubMed ID: 32478917
[TBL] [Abstract][Full Text] [Related]
35. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
36. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
Yosry A; Soliman ZA; Eletreby R; Hamza I; Ismail A; Elkady MA
Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):345-351. PubMed ID: 30312183
[TBL] [Abstract][Full Text] [Related]
37. Pro: The Role of Albumin in Pre-Liver Transplant Management.
Bernardi M; Zaccherini G; Caraceni P
Liver Transpl; 2019 Jan; 25(1):128-134. PubMed ID: 30346096
[TBL] [Abstract][Full Text] [Related]
38. Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease.
Shigefuku R; Iwasa M; Eguchi A; Tamai Y; Yoshikawa K; Sugimoto R; Takei Y
J Gastroenterol Hepatol; 2021 Apr; 36(4):1006-1014. PubMed ID: 32790956
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
Heinzow HS; Lenz P; Köhler M; Reinecke F; Ullerich H; Domschke W; Domagk D; Meister T
World J Gastroenterol; 2012 Oct; 18(37):5211-8. PubMed ID: 23066315
[TBL] [Abstract][Full Text] [Related]
40. Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score.
Hsieh YC; Lee KC; Wang YW; Yang YY; Hou MC; Huo TI; Lin HC
PLoS One; 2018; 13(12):e0208903. PubMed ID: 30540824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
